Immunotec Inc (IMMTF) 0.2250 $IMMTF
Immunotec Is Not Immune To Taxes
Duane Bair - at Seeking Alpha - Thu Feb 05, 7:23AM CST
Immunotec Reports 2014 Year-End Results
Marketwired - Mon Jan 26, 4:11PM CST
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced its year-end consolidated financial results for Fiscal 2014. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated.
IMM.VN: 0.285 (unch)
New Study Demonstrates Immunocal(R) Supplementation Increases Muscle Strength in Elderly Adults
Marketwired - Thu Nov 27, 3:03PM CST
Immunotec Inc. (TSX VENTURE: IM) a direct-to-consumer company, a leader in the nutritional industry (the "Company" or "Immunotec" and Institut de recherches cliniques de Montreal (IRCM) are pleased to announce important findings from this double-blind-randomized controlled study in elderly adults between the ages of 65 and 88. The results show that Immunocal(R) with statistical significance imparts a performance benefit of approximately 10 per cent in muscle strength. This is very relevant for healthy aging, as the process is typically associated with a decrease in muscle strength that may contribute to disability in old age and to loss of quality of life.
IMM.VN: 0.285 (unch)
Immunotec Celebrates a Fourth Anniversary in Mexico and Announces the Appointment of a New Director
Marketwired - Thu Oct 30, 3:48PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec" , today announced the appointment of a new director and celebration of the fourth anniversary of its presence in Mexico.
IMM.VN: 0.285 (unch)
Immunotec Opens New Sales Office in Commerce, California, U.S.A.
Marketwired - Tue Oct 21, 8:17PM CDT
Immunotec Inc. (TSX VENTURE: IMM) is proud to announce the opening of its new Sales Office in Commerce, California, U.S.A. With the considerable growth of Independent Distributors and increased sales throughout the southwestern region of the United States of America, a greater need for support of the regional Independent Distributors has become apparent. As a result, Immunotec has opened a 7,200 square foot full-service sales facility that is equipped to meet the needs of the Independent Distributors. The office officially opened for business on Monday, October 20, 2014.
IMM.VN: 0.285 (unch)
Immunotec Inc.: Immunocal(R) Used in Novel Prehabilitation Study
Marketwired - Tue Oct 14, 3:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry announces the completion of a first research collaboration with Dr. Franco Carli MD, MPh, Anesthesiologist at the McGill University Health Centre (MUHC), Montreal, Quebec, Canada. Immunocal(R) was used as part of the trimodal intervention Prehabilitation study sponsored by MUHC with support provided by the Montreal General Hospital Foundation and the Perioperative Program (POP).The results of this study were published electronically in the July 29, 2014 issue of Anesthesiology(1) and most recently presented at the American Congress of Rehabilitation Medicine (ACRM) 91st Annual Conference 'Progress in Rehabilitation Research' held in Toronto on October 7-11, 2014.
IMM.VN: 0.285 (unch)
Immunotec Announces Third Quarter 2014 Results
Marketwire - Mon Sep 29, 6:11PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec" , released results for the three- and nine-month periods ending on 31 July 2014. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated.
IMM.VN: 0.285 (unch)
Immunotec to Appeal Recent Court Decision in Mexico
Marketwire - Mon Sep 15, 4:45PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec" , announces its decision to appeal a recent unfavourable taxation court ruling in Mexico. The decision, received last week, denied certain favourable value-added tax ("VAT" refund requests based on an alleged misclassification of Immunocal products for VAT purposes in what the Company and many other market participants in Mexico believe is the absence of clear regulations.
IMM.VN: 0.285 (unch)
Immunotec Files a Preliminary Short Form Prospectus
Marketwire - Thu Jul 03, 4:53PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a Canadian-based company and a leader in the wellness industry (the "Company" or "Immunotec" , is pleased to announce that it has filed a preliminary short form prospectus with the securities regulatory authorities in each of the provinces of Canada in connection with a treasury offering of common shares ("Common Shares" in the capital of the Company (the "Primary Shares" and a secondary offering of Common Shares (the "Secondary Shares" and collectively with the Primary Shares, the "Offered Securities" by two selling shareholders of the Company (the "Selling Shareholders" for gross proceeds of $7 million to $15 million (the "Offering" .
IMM.VN: 0.285 (unch)
Rowing Canada Aviron and Immunotec Inc. Announce Winning Clubs for Visit from National Team Members
Marketwire - Wed Jun 11, 3:29PM CDT
Rowing Canada Aviron and Immunotec Inc. are pleased to announce the winning rowing clubs for the Club and Coach Grant, Powered by Immunocal(R). The winning clubs will receive a visit from a National Team Coach and National Senior Team Athlete along with a $1,000 grant to be used to help the club maximise the opportunity of the visit.
IMM.VN: 0.285 (unch)
Immunotec Is Not Immune To Taxes
Duane Bair - at Seeking Alpha - Thu Feb 05, 7:23AM CST
Immunotec Reports 2014 Year-End Results
Marketwired - Mon Jan 26, 4:11PM CST
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced its year-end consolidated financial results for Fiscal 2014. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated. IMM.VN: 0.285 (unch)
New Study Demonstrates Immunocal(R) Supplementation Increases Muscle Strength in Elderly Adults
Marketwired - Thu Nov 27, 3:03PM CST
Immunotec Inc. (TSX VENTURE: IM) a direct-to-consumer company, a leader in the nutritional industry (the "Company" or "Immunotec"
and Institut de recherches cliniques de Montreal (IRCM) are pleased to announce important findings from this double-blind-randomized controlled study in elderly adults between the ages of 65 and 88. The results show that Immunocal(R) with statistical significance imparts a performance benefit of approximately 10 per cent in muscle strength. This is very relevant for healthy aging, as the process is typically associated with a decrease in muscle strength that may contribute to disability in old age and to loss of quality of life. IMM.VN: 0.285 (unch)
Immunotec Celebrates a Fourth Anniversary in Mexico and Announces the Appointment of a New Director
Marketwired - Thu Oct 30, 3:48PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, today announced the appointment of a new director and celebration of the fourth anniversary of its presence in Mexico. IMM.VN: 0.285 (unch)
Immunotec Opens New Sales Office in Commerce, California, U.S.A.
Marketwired - Tue Oct 21, 8:17PM CDT
Immunotec Inc. (TSX VENTURE: IMM) is proud to announce the opening of its new Sales Office in Commerce, California, U.S.A. With the considerable growth of Independent Distributors and increased sales throughout the southwestern region of the United States of America, a greater need for support of the regional Independent Distributors has become apparent. As a result, Immunotec has opened a 7,200 square foot full-service sales facility that is equipped to meet the needs of the Independent Distributors. The office officially opened for business on Monday, October 20, 2014.
IMM.VN: 0.285 (unch)
Immunotec Inc.: Immunocal(R) Used in Novel Prehabilitation Study
Marketwired - Tue Oct 14, 3:01PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry announces the completion of a first research collaboration with Dr. Franco Carli MD, MPh, Anesthesiologist at the McGill University Health Centre (MUHC), Montreal, Quebec, Canada. Immunocal(R) was used as part of the trimodal intervention Prehabilitation study sponsored by MUHC with support provided by the Montreal General Hospital Foundation and the Perioperative Program (POP).The results of this study were published electronically in the July 29, 2014 issue of Anesthesiology(1) and most recently presented at the American Congress of Rehabilitation Medicine (ACRM) 91st Annual Conference 'Progress in Rehabilitation Research' held in Toronto on October 7-11, 2014.
IMM.VN: 0.285 (unch)
Immunotec Announces Third Quarter 2014 Results
Marketwire - Mon Sep 29, 6:11PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, released results for the three- and nine-month periods ending on 31 July 2014. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated. IMM.VN: 0.285 (unch)
Immunotec to Appeal Recent Court Decision in Mexico
Marketwire - Mon Sep 15, 4:45PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"
, announces its decision to appeal a recent unfavourable taxation court ruling in Mexico. The decision, received last week, denied certain favourable value-added tax ("VAT" refund requests based on an alleged misclassification of Immunocal products for VAT purposes in what the Company and many other market participants in Mexico believe is the absence of clear regulations. IMM.VN: 0.285 (unch)
Immunotec Files a Preliminary Short Form Prospectus
Marketwire - Thu Jul 03, 4:53PM CDT
Immunotec Inc. (TSX VENTURE: IMM), a Canadian-based company and a leader in the wellness industry (the "Company" or "Immunotec"
, is pleased to announce that it has filed a preliminary short form prospectus with the securities regulatory authorities in each of the provinces of Canada in connection with a treasury offering of common shares ("Common Shares" in the capital of the Company (the "Primary Shares" and a secondary offering of Common Shares (the "Secondary Shares" and collectively with the Primary Shares, the "Offered Securities" by two selling shareholders of the Company (the "Selling Shareholders" for gross proceeds of $7 million to $15 million (the "Offering" . IMM.VN: 0.285 (unch)
Rowing Canada Aviron and Immunotec Inc. Announce Winning Clubs for Visit from National Team Members
Marketwire - Wed Jun 11, 3:29PM CDT
Rowing Canada Aviron and Immunotec Inc. are pleased to announce the winning rowing clubs for the Club and Coach Grant, Powered by Immunocal(R). The winning clubs will receive a visit from a National Team Coach and National Senior Team Athlete along with a $1,000 grant to be used to help the club maximise the opportunity of the visit.
IMM.VN: 0.285 (unch)
